YouTube Facebook LinkedIn Google+ Twitter Xingrss  



January 13, 2003 | Bio-IT World is delighted to announce the formation of its inaugural editorial advisory board. This august group of 12 industry leaders, spanning the vast terrain of the bio-IT landscape, will provide us with expert opinion and counsel on the scope and direction of Bio-IT World, as well as timely assistance on a range of allied projects under development.

As always, we welcome reader feedback directly (kevin_davies@bio-itworld.com), but our board members will also serve as a conduit for any comments and suggestions you may have.

Beth E. Arnold, Esq.
Foley Hoag LLP
Boston, Mass.

Jeffrey Augen
President
TurboWorx Inc.
New Haven, Conn.

Mark Boguski, M.D., Ph.D.
Visiting Investigator
Fred Hutchinson Cancer Research Center
Seattle, Wash.

Greg Brandeau
CIO
Perlegen Sciences Inc.
Mountain View, Calif.

Steve Dickman
Principal
Techno Venture Management
Boston, Mass.

Richard Dweck
CEO
3rd Millennium Inc.
Cambridge, Mass.

Jim Golden, Ph.D.
Business Development Manager
454 Corp.
Branford, Conn.

Debra S. Goldfarb
Group Vice President, Worldwide Systems & Life Sciences Research
IDC
Framingham, Mass.

Caroline Kovac, Ph.D.
General Manager
IBM Life Sciences
White Plains, N.Y.

John V. W. Reynders, Ph.D.
Vice President, Informatics
Celera Genomics
Rockville, Md.

Thomas E. Sullivan, M.D.
President
Massachusetts Medical Society
Danvers, Mass.

Bernard P. Wess Jr.
President
PERSEID Software Ltd.
Needham Heights, Mass.

 


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.